Table 2.

Analysis of microglial process accumulation based on repeated-measures ANOVAs conducted at each distance from the CMB with condition (nondiabetic and diabetic) as a factor over time (0–60 min)

Distance	Condition	Time	Interaction
5–10 μm	F(1,23) = 2.76, p = 0.11	F(15,345) = 98.11, p < 0.001*	F(15,345) = 1.45, p = 0.11
10–15 μm	F(1,23) = 0.47, p = 0.50	F(15,345) = 62.07, p < 0.001*	F(15,345) = 0.43, p = 0.97
15–20 μm	F(1,23) = 8.17, p < 0.01*	F(15,345) = 39.49, p < 0.001*	F(15,345) = 3.48, p < 0.001*
20–25 μm	F(1,23) = 10.16, p < 0.01*	F(15,345) = 14.54, p < 0.001*	F(15,345) = 2.43, p < 0.01*
25–30 μm	F(1,23) = 5.21, p < 0.05*	F(15,345) = 6.87, p < 0.001*	F(15,345) = 4.49, p < 0.001*
30–35 μm	F(1,23) = 11.16, p < 0.01*	F(15,345) = 1.09, p = 0.36	F(15,345) = 3.94, p < 0.001*

*Significant main effects.